| Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|
| Income Statement | |||
| Total Revenue | |||
| Gross Profit | $ -2.70M | $ -965.05K | $ -123.08K |
| Operating Income | $ -16.90M | $ -5.03M | $ -2.95M |
| EBITDA | $ -16.35M | $ -4.96M | $ -2.95M |
| Net Income | $ -16.81M | $ -6.06M | $ -3.01M |
| Balance Sheet | |||
| Cash & Short-Term Investments | $ ― | $ ― | $ ― |
| Total Assets | $ 61.57M | $ 8.14M | $ 1.68M |
| Total Debt | $ 0.00 | $ 150.00K | $ 150.00K |
| Net Debt | $ -40.13M | $ -1.56M | $ -724.70K |
| Total Liabilities | $ 5.26M | $ 1.16M | $ 700.75K |
| Stockholders' Equity | $ ― | $ ― | $ ― |
| Cash Flow | |||
| Free Cash Flow | $ -28.57M | $ -11.76M | - |
| Operating Cash Flow | $ -19.28M | $ -6.06M | - |
| Investing Cash Flow | |||
| Financing Cash Flow |
Hynion AS Class A Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.